GlassScriptPhysician profile
Daniela Fanto
NPI 1861888018
$2,287.06
in general payments reported to CMS, 2019-2025
8 companies · $1,363 in 2025
The $1,363 reported for 2025 was more than what 91% of Family Medicine providers received nationally (typical 2025 total: $153).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $43.76 · 2020: $22.05 · 2024: $858 · 2025: $1,363.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $2,221.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $2,221.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Viiv Healthcare Company | $1,633.64 | 2024-2025 | Dovato, Cabenuva, Apretude |
| Gilead Sciences, INC. | $223.88 | 2024-2025 | Biktarvy |
| Merck Sharp & Dohme LLC | $181.32 | 2024-2025 | Pifeltro, Delstrigo, Capvaxive |
| Glaxosmithkline, LLC. | $90.79 | 2019-2025 | Arexvy |
| Emd Serono, INC. | $80.86 | 2024-2025 | |
| Theratechnologies INC. | $36.41 | 2025 | Trogarzo, Egrifta |
| Abbvie INC. | $21.42 | 2025 | |
| Hologic Sales and Service, LLC | $18.74 | 2025 | Aptima |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Daniela Fanto listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.